- Home
- FOLD vs CDE Comparison
FOLD vs CDE Comparison
Compare FOLD & CDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- CDE
- Stock Information
- Founded
- FOLD 2002
- CDE 1928
- Country
- FOLD United States
- CDE United States
- Employees
- FOLD N/A
- CDE N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- CDE Precious Metals
- Sector
- FOLD Health Care
- CDE Basic Materials
- Exchange
- FOLD Nasdaq
- CDE Nasdaq
- Market Cap
- FOLD 2.8B
- CDE 2.8B
- IPO Year
- FOLD 2007
- CDE N/A
- Fundamental
- Price
- FOLD $9.50
- CDE $6.63
- Analyst Decision
- FOLD Strong Buy
- CDE Strong Buy
- Analyst Count
- FOLD 8
- CDE 4
- Target Price
- FOLD $17.57
- CDE $7.81
- AVG Volume (30 Days)
- FOLD 2.4M
- CDE 10.6M
- Earning Date
- FOLD 11-06-2024
- CDE 11-06-2024
- Dividend Yield
- FOLD N/A
- CDE N/A
- EPS Growth
- FOLD N/A
- CDE N/A
- EPS
- FOLD N/A
- CDE N/A
- Revenue
- FOLD $493,671,000.00
- CDE $1,010,652,000.00
- Revenue This Year
- FOLD $33.97
- CDE $29.20
- Revenue Next Year
- FOLD $21.74
- CDE $37.70
- P/E Ratio
- FOLD N/A
- CDE N/A
- Revenue Growth
- FOLD 32.58
- CDE 31.38
- 52 Week Low
- FOLD $9.02
- CDE $2.42
- 52 Week High
- FOLD $14.57
- CDE $7.72
- Technical
- Relative Strength Index (RSI)
- FOLD 28.33
- CDE 52.68
- Support Level
- FOLD $9.37
- CDE $6.38
- Resistance Level
- FOLD $9.68
- CDE $6.68
- Average True Range (ATR)
- FOLD 0.49
- CDE 0.32
- MACD
- FOLD -0.18
- CDE 0.04
- Stochastic Oscillator
- FOLD 3.96
- CDE 95.38
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada Mexico, and North America.